Increased risk for ovarian cancer and borderline ovarian tumours in subfertile women with endometriosis
Open accessThe DOI matches its Crossref record; 10 of the 10 references it cites were found in a registry or an index.
Abstract
STUDY QUESTION: Is ovarian or extra-ovarian endometriosis associated with an increased risk of ovarian cancer and borderline ovarian tumours (BOT)? SUMMARY ANSWER: We found a 3- to 8-fold increased risk of ovarian tumours associated with endometriosis: the magnitude of the risk increase depended on the definition of endometriosis. WHAT IS KNOWN ALREADY: There is increasing evidence of an association between endometriosis and increased risk of ovarian cancer. However, most reports were based on self-reported diagnosis of endometriosis. STUDY DESIGN, SIZE, DURATION: We conducted a nationwide historic cohort study among women with subfertility problems between 1980 and 1995. For this analysis we selected all cohort members with endometriosis, and a comparison group of subfertile women (male factor or idiopathic) without endometriosis (total cohort of 8904 women). Median follow-up time was 15.2 for the entire study population. PARTICIPANTS/MATERIALS, SETTING, METHODS: For this analysis we selected all cohort members with (n = 3657) and without (n = 5247) evidence of endometriosis. Seventy-eight per cent of diagnoses of endometriosis were confirmed by pathology report, and 22% was self-reported endometriosis (positive predictive value of 73%). We linked the cohort with the Dutch Pathology Database and the Netherlands Cancer Registry to assess the occurrence of ovarian cancer and BOT between January 1989 and June 2007. MAIN RESULTS AND THE ROLE OF CHANCE: We observed a substantially increased risk of all ovarian malignancies combined in women with endometriosis when we based the definition of endometriosis on self-report, medical records information at subfertility treatment and/or the nationwide pathology database (hazard ratio (HR) 8.2; 95% confidence interval (CI) 3.1-21.6). The HR associated with endometriosis was 12.4 (95% CI 2.8-54.2) for ovarian cancer and 5.5 (95% CI 1.5-20.2) for BOT. When we excluded information from the pathology database, HRs were 3.0 (95% CI 1.5-6.1) for all ovarian tumours, 4.3 (95% CI 1.6-11.2) for ovarian cancer and 1.9 (95% CI 0.6-5.8) for BOT. Both ovarian and extra-ovarian endometriosis carried a significantly increased risk for ovarian cancer and BOT. LIMITATIONS, REASONS FOR CAUTION: We did not have information on oral contraceptive use and parity for 23.4 and 3.4%, of women in the analytic cohort, respectively. Furthermore, a limitation of our study, and also of other studies, is that the date of diagnosis of endometriosis is usually made long after the onset of the disease. Also, the number of cases in the cohort is small (n = 34), resulting in wide CIs. WIDER IMPLICATIONS OF THE FINDINGS: The fact that endometriosis was assessed before diagnosis of ovarian malignancy and the high degree of medical confirmation in our study likely contribute to the validity of our estimate of a 3- to 8-fold increased risk of ovarian tumours associated with endometriosis. The risk of ovarian malignancies associated with endometriosis was much higher in analyses including information on endometriosis from the nationwide pathology database, implying that risk estimates from studies using self-reported information on endometriosis may be too low due to non-differential misclassification bias. STUDY FUNDING/COMPETING INTEREST(S): None. TRIAL REGISTRATION NUMBER: None.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Giudice, L. C., & Kao, L. C. (2004) · The Lancet · doi:10.1016/s0140-6736(04)17403-5 · Cited by 3,166
Janssen, E. B., Rijkers, A. C. M., Hoppenbrouwers, K., Meuleman, C., & D'Hooghe, T. M. (2013) · Human Reproduction Update · doi:10.1093/humupd/dmt016 · Cited by 318
Kobayashi, H., Sumimoto, K., Moniwa, N., Imai, M., Takakura, K., Kuromaki, T., Morioka, E., Arisawa, K., & Terao, T. (2007) · International Journal of Gynecological Cancer · doi:10.1111/j.1525-1438.2006.00754.x · Cited by 305
Ogawa, S., Kaku, T., Amada, S., Kobayashi, H., Hirakawa, T., Ariyoshi, K., Kamura, T., & Nakano, H. (2000) · Gynecologic Oncology · doi:10.1006/gyno.2000.5765 · Cited by 279
Ovarian and extraovarian endometriosis-associated cancer
Modesitt, S. (2002) · Obstetrics & Gynecology · doi:10.1016/s0029-7844(02)02149-x · Cited by 242
Relationship of benign gynecologic diseases to subsequent risk of ovarian and uterine tumors
Brinton, L. A., Sakoda, L. C., Sherman, M. E., Frederiksen, K., Kjaer, S. K., Graubard, B. I., Olsen, J. H., & Mellemkjaer, L. (2005) · Cancer Epidemiology, Biomarkers & Prevention · doi:10.1158/1055-9965.epi-05-0394 · Cited by 166
Eržen, M., Rakar, S., Klančar, B., & Syrjänen, K. (2001) · Gynecologic Oncology · doi:10.1006/gyno.2001.6382 · Cited by 160
Hitti, I. F., Glasberg, S. S., & Lubicz, S. (1990) · Gynecologic Oncology · doi:10.1016/0090-8258(90)90259-n · Cited by 129
Prevalence of newly diagnosed endometriosis in women attending the general practitioner
Ferrero, S., Arena, E., Morando, A., & Remorgida, V. (2010) · International Journal of Gynecology & Obstetrics · doi:10.1016/j.ijgo.2010.03.039 · Cited by 110
Simpson, J. L., Bischoff, F. Z., Kamat, A., Buster, J. E., & Carson, S. A. (2003) · Obstetrics and Gynecology Clinics of North America · doi:10.1016/s0889-8545(02)00051-7 · Cited by 83
Cited by
Endometriosis: a high-risk population for major chronic diseases?
Kvaskoff, M., Mu, F., Terry, K. L., Harris, H. R., Poole, E. M., Farland, L., & Missmer, S. A. (2015) · Human Reproduction Update · doi:10.1093/humupd/dmv013 · Cited by 439
Endometriosis and cancer: a systematic review and meta-analysis
Kvaskoff, M., Mahamat-Saleh, Y., Farland, L. V., Shigesi, N., Terry, K. L., Harris, H. R., Roman, H., Becker, C. M., As-Sanie, S., Zondervan, K. T., et al. (2021) · Human Reproduction Update · doi:10.1093/humupd/dmaa045 · Cited by 303
Endometriosis-associated Malignancy
Krawczyk, N., Banys-Paluchowski, M., Schmidt, D., Ulrich, U., & Fehm, T. (2016) · Geburtshilfe und Frauenheilkunde · doi:10.1055/s-0035-1558239 · Cited by 107
Impact of endometriosis on risk of ovarian, endometrial and cervical cancers: A meta-analysis
li, J., Liu, R., Tang, S., Feng, F., Liu, C., Wang, L., Zhao, W., Zhang, T., Yao, Y., Wang, X., et al. (2019) · Archives of Gynecology and Obstetrics · doi:10.1007/s00404-018-4968-1 · Cited by 56
Development of ovarian cancer after excision of endometrioma
Haraguchi, H., Koga, K., Takamura, M., Makabe, T., Sue, F., Miyashita, M., Urata, Y., Izumi, G., Harada, M., Hirata, T., et al. (2016) · Fertility and Sterility · doi:10.1016/j.fertnstert.2016.07.1077 · Cited by 36
Metadata
- Authors
- Buis, C. C. M., van Leeuwen, F. E., Mooij, T. M., Burger, C. W., & on behalf of the OMEGA Project Group
- Venue
- Human Reproduction
- Publisher
- Oxford University Press (OUP)
- Published
- 2013-09-05
- Volume
- 28
- Issue
- 12
- Pages
- 3358-3369
- ISSN
- 0268-1161 (ISSN-L)
- 1460-2350
- OpenAlex
- W2140866731
- Cited by
- 84
- References
- 10
- FWCI
- 7.78
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.